{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T12:15:11Z","timestamp":1791375311660,"version":"4.3.1"},"reference-count":147,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Haematology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/s2352-3026(26)00197-3","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:06:09Z","timestamp":1791327969000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Future-proofing thalassaemia care: harnessing scalable therapies, artificial intelligence, and global collaboration"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6175-1383","authenticated-orcid":false,"given":"Hanny","family":"Al-Samkari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fouzia","family":"Aboobacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2540-6037","authenticated-orcid":false,"given":"Biree","family":"Andemariam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8558-8400","authenticated-orcid":false,"given":"Perla","family":"Eleftheriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9680-1985","authenticated-orcid":false,"given":"Hatoon","family":"Ezzat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8364-3447","authenticated-orcid":false,"given":"Dimitrios","family":"Farmakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrukh","family":"Hashmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8849-0072","authenticated-orcid":false,"given":"Shruti","family":"Kakkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9601-900X","authenticated-orcid":false,"given":"Aurelio","family":"Maggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2197-1899","authenticated-orcid":false,"given":"Antonio","family":"Piga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5032-5020","authenticated-orcid":false,"given":"Alok","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1144-8076","authenticated-orcid":false,"given":"Mohamed A","family":"Yassin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan Abbas","family":"Zaheer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3162-1849","authenticated-orcid":false,"given":"Vip","family":"Viprakasit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3935-903X","authenticated-orcid":false,"given":"Khaled M","family":"Musallam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2352-3026(26)00197-3_bib1","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.3324\/haematol.2024.286886","article-title":"Prevalence and mortality trends of hemoglobinopathies in Italy: a nationwide study","volume":"110","author":"Gianesin","year":"2025","journal-title":"Haematologica"},{"key":"10.1016\/S2352-3026(26)00197-3_bib2","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1182\/blood.2023022193","article-title":"Novel therapeutic approaches in thalassemias, sickle cell disease, and other red cell disorders","volume":"144","author":"Pinto","year":"2024","journal-title":"Blood"},{"key":"10.1016\/S2352-3026(26)00197-3_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3026(26)00173-0","article-title":"The expanding therapeutic landscape of \u03b2-thalassaemia","author":"Musallam","year":"2026","journal-title":"Lancet Haematol"},{"key":"10.1016\/S2352-3026(26)00197-3_bib4","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1016\/S2352-3026(25)00320-5","article-title":"Management of transfusion-dependent \u03b2-thalassaemia in the era of novel therapies: a prioritisation-based matrix for settings with limited resources","volume":"13","author":"Musallam","year":"2026","journal-title":"Lancet Haematol"},{"key":"10.1016\/S2352-3026(26)00197-3_bib5","article-title":"The epidemiology of thalassaemia syndromes in southeast Asia","author":"Piel","year":"2026","journal-title":"Lancet Reg Health Southeast Asia"},{"key":"10.1016\/S2352-3026(26)00197-3_bib6","series-title":"Guidelines for the management of \u03b1-thalassemia","author":"Amid","year":"2023"},{"key":"10.1016\/S2352-3026(26)00197-3_bib7","series-title":"Guidelines for the management of non-transfusion-dependent \u03b2-thalassaemia","author":"Taher","year":"2023"},{"key":"10.1016\/S2352-3026(26)00197-3_bib8","series-title":"Guidelines for the management of transfusion-dependent \u03b2-thalassaemia","author":"Taher","year":"2025"},{"key":"10.1016\/S2352-3026(26)00197-3_bib9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1750-1172-9-97","article-title":"Haemoglobinopathies in Europe: health & migration policy perspectives","volume":"9","author":"Aguilar Martinez","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/S2352-3026(26)00197-3_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00277-020-04246-5","article-title":"An assessment of the continuing medical education needs of US physicians in the management of patients with beta thalassemia","volume":"100","author":"Stacy","year":"2021","journal-title":"Ann Hematol"},{"key":"10.1016\/S2352-3026(26)00197-3_bib11","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1097\/MPH.0000000000001524","article-title":"Syrian refugees and their impact on health service delivery in the pediatric hematology\/oncology clinics across Canada","volume":"42","author":"Barry","year":"2020","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/S2352-3026(26)00197-3_bib12","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/727905","article-title":"The impact of migrations on the health services for rare diseases in Europe: the example of haemoglobin disorders","volume":"2013","author":"Angastiniotis","year":"2013","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/S2352-3026(26)00197-3_bib13","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1182\/blood-2012-10-408021","article-title":"Clinical experience with fetal hemoglobin induction therapy in patients with \u03b2-thalassemia","volume":"121","author":"Musallam","year":"2013","journal-title":"Blood"},{"key":"10.1016\/S2352-3026(26)00197-3_bib14","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJM198404053101401","article-title":"Augmentation of fetal-hemoglobin production in anemic monkeys by hydroxyurea","volume":"310","author":"Letvin","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/S2352-3026(26)00197-3_bib15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/03630269708997382","article-title":"Clinical and hematological response to hydroxyurea in a patient with Hb Lepore\/beta-thalassemia","volume":"21","author":"Rigano","year":"1997","journal-title":"Hemoglobin"},{"key":"10.1016\/S2352-3026(26)00197-3_bib16","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","article-title":"Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia","volume":"332","author":"Charache","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/S2352-3026(26)00197-3_bib17","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S0140-6736(11)60355-3","article-title":"Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)","volume":"377","author":"Wang","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2352-3026(26)00197-3_bib18","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/ajh.26286","article-title":"Real-life experience with hydroxyurea in patients with sickle cell disease: results from the prospective ESCORT-HU cohort study","volume":"96","author":"de Montalembert","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1016\/S2352-3026(26)00197-3_bib19","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1182\/blood-2013-10-534842","article-title":"Hydroxyurea-inducible SAR1 gene acts through the Gi\u03b1\/JNK\/Jun pathway to regulate \u03b3-globin expression","volume":"124","author":"Zhu","year":"2014","journal-title":"Blood"},{"key":"10.1016\/S2352-3026(26)00197-3_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1480831","article-title":"Efficacy and safety of hydroxyurea therapy on patients with \u03b2-thalassemia: a systematic review and meta-analysis","volume":"11","author":"Huang","year":"2025","journal-title":"Front Med"},{"key":"10.1016\/S2352-3026(26)00197-3_bib21","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S0140-6736(26)00874-3","article-title":"Efficacy and safety of mitapivat in adults with transfusion-dependent \u03b1-thalassaemia or \u03b2-thalassaemia (ENERGIZE-T): a double-blind, randomised, multicentre, placebocontrolled, phase 3 trial","volume":"408","author":"Cappellini","year":"2026","journal-title":"Lancet"},{"key":"10.1016\/S2352-3026(26)00197-3_bib22","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1056\/NEJMoa1910182","article-title":"A phase 3 trial of luspatercept in patients with transfusion-dependent \u03b2-thalassemia","volume":"382","author":"Cappellini","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2352-3026(26)00197-3_bib23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0140-6736(25)00635-X","article-title":"Mitapivat in adults with non-transfusion-dependent \u03b1-thalassaemia or \u03b2-thalassaemia (ENERGIZE): a phase 3, international, randomised, double-blind, placebo-controlled trial","volume":"406","author":"Taher","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/S2352-3026(26)00197-3_bib24","doi-asserted-by":"crossref","first-page":"e733","DOI":"10.1016\/S2352-3026(22)00208-3","article-title":"Luspatercept for the treatment of anaemia in non-transfusion-dependent \u03b2-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial","volume":"9","author":"Taher","year":"2022","journal-title":"Lancet Haematol"},{"key":"10.1016\/S2352-3026(26)00197-3_bib25","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1080\/14740338.2022.2064980","article-title":"The use of hydroxyurea in the real life of MIOT network: an observational study","volume":"21","author":"Ricchi","year":"2022","journal-title":"Expert Opin Drug Saf"},{"issue":"suppl 2","key":"10.1016\/S2352-3026(26)00197-3_bib26","first-page":"319","article-title":"Healing of leg ulcers with hydroxyurea in thalassaemia intermedia patients with associated endocrine complications","volume":"2","author":"Gamberini","year":"2004","journal-title":"Pediatr Endocrinol Rev"},{"key":"10.1016\/S2352-3026(26)00197-3_bib27","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1182\/blood-2009-09-243154","article-title":"Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study","volume":"115","author":"Taher","year":"2010","journal-title":"Blood"},{"key":"10.1016\/S2352-3026(26)00197-3_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-06774-8","article-title":"A randomised double-blind placebo-controlled clinical trial of oral hydroxyurea for transfusion-dependent \u03b2-thalassaemia","volume":"12","author":"Yasara","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/S2352-3026(26)00197-3_bib29","article-title":"Hydroxyurea for reducing blood transfusion in non-transfusion dependent beta thalassaemias","volume":"10","author":"Foong","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2352-3026(26)00197-3_bib30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cca.2009.06.019","article-title":"Response to hydroxyurea in beta thalassemia major and intermedia: experience in western India","volume":"407","author":"Italia","year":"2009","journal-title":"Clin Chim Acta"},{"key":"10.1016\/S2352-3026(26)00197-3_bib31","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2141.2010.08397.x","article-title":"Desensitization to hydroxycarbamide following long-term treatment of thalassaemia intermedia as observed in vivo and in primary erythroid cultures from treated patients","volume":"151","author":"Rigano","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/S2352-3026(26)00197-3_bib32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2141.2006.06002.x","article-title":"Treatment with hydroxycarbamide for intermedia thalassaemia: decrease of efficacy in some patients during long-term follow up","volume":"133","author":"Mancuso","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/S2352-3026(26)00197-3_bib33","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s12185-017-2307-0","article-title":"Hydroxyurea for hemoglobin E\/\u03b2-thalassemia: a systematic review and meta-analysis","volume":"106","author":"Algiraigri","year":"2017","journal-title":"Int J Hematol"},{"key":"10.1016\/S2352-3026(26)00197-3_bib34","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/ejh.12204","article-title":"Quantification of HBG mRNA in primary erythroid cultures: prediction of the response to hydroxyurea in sickle cell and beta-thalassemia","volume":"92","author":"Pecoraro","year":"2014","journal-title":"Eur J Haematol"},{"key":"10.1016\/S2352-3026(26)00197-3_bib35","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/ejh.12182","article-title":"Therapeutic superiority and safety of combined hydroxyurea with recombinant human erythropoietin over hydroxyurea in young \u03b2-thalassemia intermedia patients","volume":"91","author":"Elalfy","year":"2013","journal-title":"Eur J Haematol"},{"key":"10.1016\/S2352-3026(26)00197-3_bib36","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1007\/s00277-021-04627-4","article-title":"Long-term safety and efficacy of hydroxyurea in patients with non-transfusion-dependent \u03b2-thalassemia: a comprehensive single-center experience","volume":"100","author":"Karimi","year":"2021","journal-title":"Ann Hematol"},{"key":"10.1016\/S2352-3026(26)00197-3_bib37","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/j.1537-2995.2007.01399.x","article-title":"Decreased transfusion needs associated with hydroxyurea therapy in Algerian patients with thalassemia major or intermedia","volume":"47","author":"Bradai","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/S2352-3026(26)00197-3_bib38","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ajh.21699","article-title":"The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: a 17.5 year follow-up","volume":"85","author":"Steinberg","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1016\/S2352-3026(26)00197-3_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogc.2025.102924","article-title":"Safety of hydroxyurea in pregnancy: a systematic review of the literature","volume":"47","author":"Al Sulaimani","year":"2025","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/S2352-3026(26)00197-3_bib40","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/jb\/mvad113","article-title":"Protein degraders\u2014from thalidomide to new PROTACs","volume":"175","author":"Ito","year":"2024","journal-title":"J Biochem"},{"key":"10.1016\/S2352-3026(26)00197-3_bib41","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.clinthera.2025.01.008","article-title":"Effects of thalidomide on metabolism and lifespan of red blood cell in patients with \u03b2-thalassemia major: a post hoc analysis of a randomized controlled trial","volume":"47","author":"Yang","year":"2025","journal-title":"Clin Ther"},{"key":"10.1016\/S2352-3026(26)00197-3_bib42","article-title":"Thalidomide confers therapeutic benefit in beta thalassemia patients by enhancing hemoglobin and hematopoietic gene expression: a non-randomized clinical trial","volume":"113\u2013114","author":"Rahman","year":"2025","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/S2352-3026(26)00197-3_bib43","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41598-026-46504-y","article-title":"Efficacy and safety of thalidomide in \u03b2-thalassaemia: a systematic review and meta-analysis","volume":"16","author":"Yasara","year":"2026","journal-title":"Sci Rep"},{"key":"10.1016\/S2352-3026(26)00197-3_bib44","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1080\/14622416.2026.2622318","article-title":"Association of CYP2C19 gene single nucleotide polymorphisms (rs12248560 and rs4244285) with response to thalidomide in transfusion dependent \u03b2-thalassemia patients\u2014a 12-months follow-up study","volume":"26","author":"Ur Rahman","year":"2025","journal-title":"Pharmacogenomics"},{"key":"10.1016\/S2352-3026(26)00197-3_bib45","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.20038","article-title":"Genetic modifiers of response to thalidomide in transfusion-dependent beta-thalassemia patients: a whole-exome sequence analysis","volume":"13","author":"Bawazir","year":"2025","journal-title":"PeerJ"},{"key":"10.1016\/S2352-3026(26)00197-3_bib46","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12920-024-01963-y","article-title":"Clinical efficacy of thalidomide for various genotypes of beta thalassemia","volume":"17","author":"Yang","year":"2024","journal-title":"BMC Med Genomics"},{"key":"10.1016\/S2352-3026(26)00197-3_bib47","first-page":"1519","article-title":"Predictors of hematologic responses in patients with non-transfusion-dependent \u03b2-thalassemia receiving thalidomide therapy","volume":"30","author":"Yang","year":"2022","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"10.1016\/S2352-3026(26)00197-3_bib48","article-title":"Efficacy of thalidomide treatment in children with transfusion dependent \u03b2-thalassemia: a retrospective clinical study","volume":"12","author":"Li","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/S2352-3026(26)00197-3_bib49","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41392-021-00811-0","article-title":"Safety and efficacy of thalidomide in patients with transfusion-dependent \u03b2-thalassemia: a randomized clinical trial","volume":"6","author":"Chen","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/S2352-3026(26)00197-3_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcmd.2020.102442","article-title":"The association of HBG2, BCL11A, and HBS1L-MYB polymorphisms to thalidomide response in Chinese \u03b2-thalassemia patients","volume":"84","author":"Yang","year":"2020","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/S2352-3026(26)00197-3_bib51","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s12288-020-01263-2","article-title":"Thalidomide in patients with transfusion-dependent e-beta thalassemia refractory to hydroxyurea: a single-center experience","volume":"36","author":"Nag","year":"2020","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/S2352-3026(26)00197-3_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcmd.2021.102544","article-title":"Comparison of efficacy and safety of thalidomide vs hydroxyurea in patients with Hb E-\u03b2 thalassemia\u2014a pilot study from a tertiary care centre of India","volume":"88","author":"Jain","year":"2021","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/S2352-3026(26)00197-3_bib53","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/03630269.2025.2473526","article-title":"Evaluating health-related quality of life in thalassemia: low-dose thalidomide vs. standard care-insights from a comparative study","volume":"49","author":"Mishra","year":"2025","journal-title":"Hemoglobin"},{"key":"10.1016\/S2352-3026(26)00197-3_bib54","article-title":"Effects of thalidomide on endothelial activation and stress index in children with \u03b2-thalassemia major","volume":"16","author":"Chen","year":"2024","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/S2352-3026(26)00197-3_bib55","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2025019459","article-title":"Efficacy and safety of thalidomide (1 vs 2 mg\/kg\/d) in transfusion-dependent thalassemia: a non-inferiority trial","author":"Kakkar","year":"2026","journal-title":"Blood Adv"},{"key":"10.1016\/S2352-3026(26)00197-3_bib56","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2147\/TCRM.S481128","article-title":"Comparison of efficacy and safety outcomes of different doses schedules of thalidomide for treating moderate-to-severe \u03b2-thalassemia patients","volume":"20","author":"Yang","year":"2024","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/S2352-3026(26)00197-3_bib57","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.2147\/IJGM.S462991","article-title":"Long-term follow-up of patients undergoing thalidomide therapy for transfusion-dependent \u03b2-thalassaemia: a single-center experience","volume":"17","author":"Zhu","year":"2024","journal-title":"Int J Gen Med"},{"key":"10.1016\/S2352-3026(26)00197-3_bib58","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s13312-025-3363-9","article-title":"Acute lymphoblastic leukemia developing in children with thalassemia exposed to thalidomide: a case series","volume":"62","author":"Khurana","year":"2025","journal-title":"Indian Pediatr"},{"key":"10.1016\/S2352-3026(26)00197-3_bib59","article-title":"Thalidomide-induced primary amenorrhea in a patient with HbE\/beta-thalassemia","volume":"1","author":"Singha","year":"2023","journal-title":"JCEM Case Rep"},{"key":"10.1016\/S2352-3026(26)00197-3_bib60","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30982","article-title":"Secondary amenorrhea in a \u03b2-thalassemia major patient treated with thalidomide","volume":"71","author":"Yu","year":"2024","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/S2352-3026(26)00197-3_bib61","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/03630269.2024.2386076","article-title":"Thalidomide and hydroxyurea in transfusion-dependent thalassemia: efficacy, safety profile and impact on quality of life","volume":"48","author":"Bhattacharjee","year":"2024","journal-title":"Hemoglobin"},{"key":"10.1016\/S2352-3026(26)00197-3_bib62","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s00277-021-04501-3","article-title":"Experience with combination of hydroxyurea and low-dose thalidomide in transfusion-dependent beta thalassemia patients","volume":"100","author":"Bhurani","year":"2021","journal-title":"Ann Hematol"},{"key":"10.1016\/S2352-3026(26)00197-3_bib63","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12288-022-01536-y","article-title":"Safety and efficacy of thalidomide and hydroxyurea combination in beta thalassemia patients","volume":"39","author":"Garg","year":"2023","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/S2352-3026(26)00197-3_bib64","doi-asserted-by":"crossref","first-page":"6162","DOI":"10.1182\/bloodadvances.2022007031","article-title":"Evaluation of the combination therapy of hydroxyurea and thalidomide in \u03b2-thalassemia","volume":"6","author":"Ansari","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/S2352-3026(26)00197-3_bib65","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1111\/bjh.16272","article-title":"Safety and effectiveness of thalidomide and hydroxyurea combination in \u03b2-thalassaemia intermedia and major: a retrospective pilot study","volume":"188","author":"Shah","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/S2352-3026(26)00197-3_bib66","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s12288-022-01620-3","article-title":"A phase 2 randomized controlled trial of single-agent hydroxyurea versus thalidomide among adult transfusion dependent \u03b2 thalassemia patients","volume":"39","author":"Bhattacharjee","year":"2023","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/S2352-3026(26)00197-3_bib67","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1111\/bjh.16670","article-title":"High-level induction of fetal haemoglobin by pomalidomide in \u03b2-thalassaemia\/HbE erythroid progenitor cells","volume":"189","author":"Khamphikham","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/S2352-3026(26)00197-3_bib68","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1172\/JCI32322","article-title":"Pomalidomide and lenalidomide regulate erythropoiesis and fetal hemoglobin production in human CD34+ cells","volume":"118","author":"Moutouh-de Parseval","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/S2352-3026(26)00197-3_bib69","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1111\/jth.15354","article-title":"Thrombotic and bleeding risk of angiogenesis inhibitors in patients with and without malignancy","volume":"19","author":"Watson","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/S2352-3026(26)00197-3_bib70","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12911-019-0929-2","article-title":"ThalPred: a web-based prediction tool for discriminating thalassemia trait and iron deficiency anemia","volume":"19","author":"Laengsri","year":"2019","journal-title":"BMC Med Inform Decis Mak"},{"key":"10.1016\/S2352-3026(26)00197-3_bib71","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1080\/13696998.2026.2649528","article-title":"Cost-effectiveness of exagamglogene autotemcel gene-edited therapy in patients with transfusion-dependent \u03b2-thalassemia in the United States","volume":"29","author":"Udeze","year":"2026","journal-title":"J Med Econ"},{"key":"10.1016\/S2352-3026(26)00197-3_bib72","doi-asserted-by":"crossref","DOI":"10.1080\/20016689.2021.1922028","article-title":"Economic evaluation of betibeglogene autotemcel (Beti-cel) gene addition therapy in transfusion-dependent \u03b2-thalassemia","volume":"9","author":"Kansal","year":"2021","journal-title":"J Mark Access Health Policy"},{"key":"10.1016\/S2352-3026(26)00197-3_bib73","doi-asserted-by":"crossref","first-page":"e931","DOI":"10.1016\/S2352-3026(25)00282-0","article-title":"A communitarian approach to cell therapy and gene therapy access in low-income and middle-income countries","volume":"12","author":"Koranteng","year":"2025","journal-title":"Lancet Haematol"},{"key":"10.1016\/S2352-3026(26)00197-3_bib74","doi-asserted-by":"crossref","DOI":"10.1111\/cts.70561","article-title":"Thailand's emerging role in the cell and gene therapy revolution: a review of progress and potential","volume":"19","author":"Viprakasit","year":"2026","journal-title":"Clin Transl Sci"},{"key":"10.1016\/S2352-3026(26)00197-3_bib75","doi-asserted-by":"crossref","first-page":"e869","DOI":"10.1016\/S2352-3026(22)00356-8","article-title":"Gene therapy in China: past, present, and future","volume":"9","author":"Zhang","year":"2022","journal-title":"Lancet Haematol"},{"key":"10.1016\/S2352-3026(26)00197-3_bib76","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41587-026-03065-9","article-title":"New rules spur cell and gene therapy trials in China","volume":"44","year":"2026","journal-title":"Nat Biotechnol"},{"key":"10.1016\/S2352-3026(26)00197-3_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcyt.2026.102064","article-title":"Futuristic global cell and gene therapy regulations based on a review of today's leading frameworks","volume":"28","author":"Hashmi","year":"2026","journal-title":"Cytotherapy"},{"key":"10.1016\/S2352-3026(26)00197-3_bib78","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41573-025-01236-y","article-title":"CRISPR-based therapeutic genome editing for inherited blood disorders","volume":"24","author":"Levesque","year":"2025","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/S2352-3026(26)00197-3_bib79","article-title":"Pathing the way from regulatory approval to market access for gene therapy products (GTPs): an integrative review in the US, EU5, Japan and China","volume":"32","author":"Shi","year":"2026","journal-title":"Regen Ther"},{"key":"10.1016\/S2352-3026(26)00197-3_bib80","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12911-026-03451-y","article-title":"A dual-modal machine learning framework integrating red blood indices and smartphone-captured microscopic images for \u03b2-thalassemia screening","volume":"26","author":"Wijesinghe","year":"2026","journal-title":"BMC Med Inform Decis Mak"},{"key":"10.1016\/S2352-3026(26)00197-3_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics13091551","article-title":"Applications of artificial intelligence in thalassemia: a comprehensive review","volume":"13","author":"Ferih","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/S2352-3026(26)00197-3_bib82","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00277-026-06894-5","article-title":"Comparison of the diagnostic performance of machine learning algorithms for differentiating iron deficiency anemia and thalassemia","volume":"105","author":"Wang","year":"2026","journal-title":"Ann Hematol"},{"key":"10.1016\/S2352-3026(26)00197-3_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fdata.2025.1634133","article-title":"Basrah score: a novel machine learning-based score for differentiating iron deficiency anemia and beta thalassemia trait using RBC indices","volume":"8","author":"Mahmood","year":"2025","journal-title":"Front Big Data"},{"key":"10.1016\/S2352-3026(26)00197-3_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117329","article-title":"Predicting thalassemia using deep neural network based on red blood cell indices","volume":"543","author":"Mo","year":"2023","journal-title":"Clin Chim Acta"},{"key":"10.1016\/S2352-3026(26)00197-3_bib85","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-22011-8","article-title":"Prediction of \u03b2-thalassemia carriers using complete blood count features","volume":"12","author":"Rustam","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/S2352-3026(26)00197-3_bib86","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/ijlh.70017","article-title":"Machine learning-based prediction of \u03b2-thalassemia trait using red blood cell indices","volume":"48","author":"Payda\u015f Hataysal","year":"2026","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/S2352-3026(26)00197-3_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2021.12.003","article-title":"An online alpha-thalassemia carrier discrimination model based on random forest and red blood cell parameters for low HbA2 cases","volume":"525","author":"Feng","year":"2022","journal-title":"Clin Chim Acta"},{"key":"10.1016\/S2352-3026(26)00197-3_bib88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0331985","article-title":"From CBC to clarity: interpretable detection of beta-thalassemia carriers in imbalanced datasets","volume":"20","author":"Chishti","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/S2352-3026(26)00197-3_bib89","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1111\/ijlh.14524","article-title":"Machine learning for discriminating microcytic hypochromic anemia based on erythrocyte parameters","volume":"47","author":"Lv","year":"2025","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/S2352-3026(26)00197-3_bib90","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-01458-5","article-title":"Machine learning approach for differentiating iron deficiency anemia and thalassemia using random forest and gradient boosting algorithms","volume":"15","author":"Tepakhan","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/S2352-3026(26)00197-3_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2025.110151","article-title":"Detection of \u03b2-thalassemia trait from a heterogeneous population with red cell indices and parameters","volume":"192","author":"Saha","year":"2025","journal-title":"Comput Biol Med"},{"key":"10.1016\/S2352-3026(26)00197-3_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2024.120025","article-title":"MultiThal-classifier, a machine learning-based multi-class model for thalassemia diagnosis and classification","volume":"567","author":"Wang","year":"2025","journal-title":"Clin Chim Acta"},{"key":"10.1016\/S2352-3026(26)00197-3_bib93","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/clinchem\/hvae081","article-title":"Machine learning-based prediction of hemoglobinopathies using complete blood count data","volume":"70","author":"Schipper","year":"2024","journal-title":"Clin Chem"},{"key":"10.1016\/S2352-3026(26)00197-3_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.109611","article-title":"Discrimination of \u03b2-thalassemia and iron deficiency anemia through extreme learning machine and regularized extreme learning machine based decision support system","volume":"138","author":"\u00c7il","year":"2020","journal-title":"Med Hypotheses"},{"key":"10.1016\/S2352-3026(26)00197-3_bib95","article-title":"Prediction of \u03b2-thalassemia carrier using federated learning and explainable AI","volume":"13","author":"Younas","year":"2026","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/S2352-3026(26)00197-3_bib96","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-97353-0","article-title":"A comprehensive case study of deep learning on the detection of alpha thalassemia and beta thalassemia using public and private datasets","volume":"15","author":"Nasir","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/S2352-3026(26)00197-3_bib97","article-title":"Establishment and verification of the model in diagnosis of thalassemia trait based on red blood cell parameters: a two-center retrospective study","volume":"11","author":"Liu","year":"2025","journal-title":"Digit Health"},{"key":"10.1016\/S2352-3026(26)00197-3_bib98","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics11091725","article-title":"The TVGH-NYCU Thal-Classifier: development of a machine-learning classifier for differentiating thalassemia and non-thalassemia patients","volume":"11","author":"Fu","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/S2352-3026(26)00197-3_bib99","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s12288-020-01373-x","article-title":"Role of red cell indices in screening for beta thalassemia trait: an assessment of the individual indices and application of machine learning algorithm","volume":"37","author":"Jahan","year":"2021","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/S2352-3026(26)00197-3_bib100","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/ijlh.70033","article-title":"The application of machine-learning algorithms for multiclass classification of microcytic anemia revealed that a minimum required number of hematological parameters is enough to achieve high diagnostic accuracy","volume":"48","author":"Komninaka","year":"2026","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/S2352-3026(26)00197-3_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmpb.2024.108581","article-title":"Classification of \u03b1-thalassemia data using machine learning models","volume":"260","author":"Christensen","year":"2025","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1016\/S2352-3026(26)00197-3_bib102","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s00277-026-06860-1","article-title":"Machine learning and AI-assisted red blood cell morphology analysis for effective thalassemia screening","volume":"105","author":"Gui","year":"2026","journal-title":"Ann Hematol"},{"key":"10.1016\/S2352-3026(26)00197-3_bib103","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/ejh.14160","article-title":"Enhancing thalassemia gene carrier identification in non-anemic populations using artificial intelligence erythrocyte morphology analysis and machine learning","volume":"112","author":"Zhang","year":"2024","journal-title":"Eur J Haematol"},{"key":"10.1016\/S2352-3026(26)00197-3_bib104","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4103\/jpi.jpi_110_20","article-title":"Image analysis using machine learning for automated detection of hemoglobin H inclusions in blood smears\u2014a method for morphologic detection of rare cells","volume":"12","author":"Lee","year":"2021","journal-title":"J Pathol Inform"},{"key":"10.1016\/S2352-3026(26)00197-3_bib105","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics12102405","article-title":"Deep learning assisted automated assessment of thalassaemia from haemoglobin electrophoresis images","volume":"12","author":"Salman Khan","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/S2352-3026(26)00197-3_bib106","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41746-025-01766-0","article-title":"Development and validation of an interpretable risk prediction model for the early classification of thalassemia","volume":"8","author":"Lai","year":"2025","journal-title":"NPJ Digit Med"},{"key":"10.1016\/S2352-3026(26)00197-3_bib107","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-06594-6","article-title":"Multiclass classification of thalassemia types using complete blood count and HPLC data with machine learning","volume":"15","author":"Nasir","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/S2352-3026(26)00197-3_bib108","doi-asserted-by":"crossref","DOI":"10.1002\/hem3.70227","article-title":"Accurate diagnosis of hemoglobinopathies with machine learning based on high-throughput proteomics","volume":"9","author":"Wei","year":"2025","journal-title":"HemaSphere"},{"key":"10.1016\/S2352-3026(26)00197-3_bib109","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-20605-6","article-title":"Machine learning improves detection of alpha thalassemia carriers compared to clinical features","volume":"15","author":"Mohammadi","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/S2352-3026(26)00197-3_bib110","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11216305","article-title":"DeepThal: a deep learning-based framework for the large-scale prediction of the \u03b1+-thalassemia trait using red blood cell parameters","volume":"11","author":"Phirom","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/S2352-3026(26)00197-3_bib111","article-title":"Evaluation of low-cost techniques to detect sickle cell disease and \u03b2-thalassemia: an open-label, international, multicentre study","volume":"35","author":"Shrestha","year":"2025","journal-title":"Lancet Reg Health Southeast Asia"},{"key":"10.1016\/S2352-3026(26)00197-3_bib112","doi-asserted-by":"crossref","DOI":"10.4084\/MJHID.2023.026","article-title":"Prevalence of thalassemia in the Vietnamese population and building a clinical decision support system for prenatal screening for thalassemia","volume":"15","author":"Tran","year":"2023","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/S2352-3026(26)00197-3_bib113","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics15222833","article-title":"A hybrid MCDM and machine learning framework for thalassemia risk assessment in pregnant women","volume":"15","author":"Johara Chowdhury","year":"2025","journal-title":"Diagnostics"},{"key":"10.1016\/S2352-3026(26)00197-3_bib114","article-title":"Development of an interpretable ensemble learning model for thalassemia detection in pregnant women using routine hematological parameters","volume":"11","author":"Wang","year":"2025","journal-title":"Digit Health"},{"key":"10.1016\/S2352-3026(26)00197-3_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmedinf.2022.104866","article-title":"Performance analysis of machine learning algorithms and screening formulae for \u03b2-thalassemia trait screening of Indian antenatal women","volume":"167","author":"Das","year":"2022","journal-title":"Int J Med Inform"},{"key":"10.1016\/S2352-3026(26)00197-3_bib116","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2025.1688645","article-title":"Interpretable machine learning models for beta thalassemia prediction: an explainable AI approach for smart healthcare 5.0","volume":"12","author":"Abbas","year":"2026","journal-title":"Front Med"},{"key":"10.1016\/S2352-3026(26)00197-3_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117368","article-title":"TT@MHA: a machine learning-based webpage tool for discriminating thalassemia trait from microcytic hypochromic anemia patients","volume":"545","author":"Zhang","year":"2023","journal-title":"Clin Chim Acta"},{"key":"10.1016\/S2352-3026(26)00197-3_bib118","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25126446","article-title":"Support vector machine-based formula for detecting suspected \u03b1 thalassemia carriers: a path toward universal screening","volume":"25","author":"Lachover-Roth","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/S2352-3026(26)00197-3_bib119","article-title":"Thalassaemia prevention in Asia: progress, challenges, and future directions","author":"Angastiniotis","year":"2026","journal-title":"Lancet Reg Health Southeast Asia"},{"key":"10.1016\/S2352-3026(26)00197-3_bib120","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1007\/s00330-024-11245-x","article-title":"Convolutional neural networks for automatic MR classification of myocardial iron overload in thalassemia major patients","volume":"35","author":"Positano","year":"2025","journal-title":"Eur Radiol"},{"key":"10.1016\/S2352-3026(26)00197-3_bib121","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/jmri.29113","article-title":"MRI deep learning-based automatic segmentation of interventricular septum for black-blood myocardial T2* measurement in thalassemia","volume":"60","author":"Lian","year":"2024","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/S2352-3026(26)00197-3_bib122","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/jmri.28300","article-title":"Deep learning staging of liver iron content from multiecho MR Images","volume":"57","author":"Positano","year":"2023","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/S2352-3026(26)00197-3_bib123","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1016\/j.acra.2025.04.075","article-title":"A mixed-attention network for automated interventricular septum segmentation in bright-blood myocardial T2* MRI relaxometry in thalassemia","volume":"32","author":"Wu","year":"2025","journal-title":"Acad Radiol"},{"key":"10.1016\/S2352-3026(26)00197-3_bib124","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/03630269.2026.2653733","article-title":"Beyond diagnosis: a systematic review of artificial intelligence and deep learning in monitoring iron overload and organ toxicity in beta-thalassemia","volume":"50","author":"Nasiri","year":"2026","journal-title":"Hemoglobin"},{"key":"10.1016\/S2352-3026(26)00197-3_bib125","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/03630269.2022.2158100","article-title":"Prediction of heart and liver iron overload in \u03b2-thalassemia major patients using machine learning methods","volume":"46","author":"Asmarian","year":"2022","journal-title":"Hemoglobin"},{"key":"10.1016\/S2352-3026(26)00197-3_bib126","doi-asserted-by":"crossref","DOI":"10.1080\/16078454.2026.2647314","article-title":"Machine learning in the prediction of liver iron concentration and iron chelation therapy adjustment","volume":"31","author":"Loh","year":"2026","journal-title":"Hematology"},{"key":"10.1016\/S2352-3026(26)00197-3_bib127","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s13318-020-00647-z","article-title":"Effect of genetic polymorphisms on the pharmacokinetics of deferasirox in healthy Chinese subjects and an artificial neural networks model for pharmacokinetic prediction","volume":"45","author":"Chen","year":"2020","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/S2352-3026(26)00197-3_bib128","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.21037\/tp-2025-385","article-title":"A predictive model for low bone mass in pediatric and adolescent patients with transfusion-dependent beta-thalassemia","volume":"14","author":"Zhang","year":"2025","journal-title":"Transl Pediatr"},{"key":"10.1016\/S2352-3026(26)00197-3_bib129","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0341168","article-title":"Explainable AI framework for improved thalassemia mental health classification and feature selection","volume":"21","author":"Ayon","year":"2026","journal-title":"PLoS One"},{"key":"10.1016\/S2352-3026(26)00197-3_bib130","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jad.2020.12.089","article-title":"Construction of an exposure-pathway-phenotype in children with depression due to transfusion-dependent thalassemia: results of (un)supervised machine learning","volume":"282","author":"Al-Hakeim","year":"2021","journal-title":"J Affect Disord"},{"key":"10.1016\/S2352-3026(26)00197-3_bib131","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.exphem.2010.02.012","article-title":"Comparison between an artificial neural network and logistic regression in predicting acute graft-vs-host disease after unrelated donor hematopoietic stem cell transplantation in thalassemia patients","volume":"38","author":"Caocci","year":"2010","journal-title":"Exp Hematol"},{"key":"10.1016\/S2352-3026(26)00197-3_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2026.111558","article-title":"Enhancing survival analysis through federated learning in non-IID and scarce data scenarios","volume":"204","author":"Apell\u00e1niz","year":"2026","journal-title":"Comput Biol Med"},{"key":"10.1016\/S2352-3026(26)00197-3_bib133","doi-asserted-by":"crossref","DOI":"10.1177\/1460458221989397","article-title":"Web-based expert system with quick response code for beta-thalassemia management","volume":"27","author":"Banjar","year":"2021","journal-title":"Health Informatics J"},{"key":"10.1016\/S2352-3026(26)00197-3_bib134","article-title":"A smart chatbot for interactive management in beta thalassemia patients","volume":"2022","author":"Alturaiki","year":"2022","journal-title":"Int J Telemed Appl"},{"key":"10.1016\/S2352-3026(26)00197-3_bib135","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ajh.21398","article-title":"The influence of treatment in specialized centers on survival of patients with thalassemia major","volume":"84","author":"Forni","year":"2009","journal-title":"Am J Hematol"},{"key":"10.1016\/S2352-3026(26)00197-3_bib136","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/thalassrep13010002","article-title":"TIF standards for haemoglobinopathy reference centres","volume":"13","author":"Angastiniotis","year":"2023","journal-title":"Thalass Rep"},{"key":"10.1016\/S2352-3026(26)00197-3_bib137","doi-asserted-by":"crossref","first-page":"e687","DOI":"10.1016\/S2352-3026(23)00182-5","article-title":"Sickle cell disease landscape and challenges in the EU: the ERN-EuroBloodNet perspective","volume":"10","author":"Ma\u00f1\u00fa Pereira","year":"2023","journal-title":"Lancet Haematol"},{"key":"10.1016\/S2352-3026(26)00197-3_bib138","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1002\/mrm.24854","article-title":"Multicenter validation of spin-density projection-assisted R2-MRI for the noninvasive measurement of liver iron concentration","volume":"71","author":"St Pierre","year":"2014","journal-title":"Magn Reson Med"},{"key":"10.1016\/S2352-3026(26)00197-3_bib139","doi-asserted-by":"crossref","first-page":"91","DOI":"10.5144\/1658-3876.2012.91","article-title":"Intersite validations of the pixel-wise method for liver R2* analysis in transfusion-dependent thalassemia patients: a more accessible and affordable diagnostic technology","volume":"5","author":"Saiviroonporn","year":"2012","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"suppl 2","key":"10.1016\/S2352-3026(26)00197-3_bib140","first-page":"S165","article-title":"Inter-site validations of the Pixel-Wise method for cardiac T2* analysis in transfusion-dependent Thai thalassemia patients","volume":"95","author":"Saiviroonporn","year":"2012","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/S2352-3026(26)00197-3_bib141","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1161\/CIRCULATIONAHA.116.022803","article-title":"Ultrafast magnetic resonance imaging for iron quantification in thalassemia participants in the developing world: the TIC-TOC study (Thailand and UK International Collaboration in Thalassaemia Optimising Ultrafast CMR)","volume":"134","author":"Abdel-Gadir","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/S2352-3026(26)00197-3_bib142","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1007\/s00330-011-2208-1","article-title":"Heart and liver T2 assessment for iron overload using different software programs","volume":"21","author":"Fernandes","year":"2011","journal-title":"Eur Radiol"},{"key":"10.1016\/S2352-3026(26)00197-3_bib143","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/bjh.17897","article-title":"Primary HBB gene mutation severity and long-term outcomes in a global cohort of \u03b2-thalassaemia","volume":"196","author":"Musallam","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/S2352-3026(26)00197-3_bib144","doi-asserted-by":"crossref","first-page":"E416","DOI":"10.1002\/ajh.26323","article-title":"The International Hemoglobinopathy Research Network (INHERENT): an international initiative to study the role of genetic modifiers in hemoglobinopathies","volume":"96","author":"Kountouris","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1016\/S2352-3026(26)00197-3_bib145","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1182\/bloodadvances.2022007823","article-title":"The impact of in utero transfusions on perinatal outcomes in patients with alpha thalassemia major: the UCSF registry","volume":"7","author":"Schwab","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/S2352-3026(26)00197-3_bib146","first-page":"481","article-title":"An ICET-A survey on occult and emerging endocrine complications in patients with \u03b2-thalassemia major: conclusions and recommendations","volume":"89","author":"De Sanctis","year":"2019","journal-title":"Acta Biomed"},{"key":"10.1016\/S2352-3026(26)00197-3_bib147","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3390\/jpm12040552","article-title":"Global Globin Network consensus paper: classification and stratified roadmaps for improved thalassaemia care and prevention in 32 countries","volume":"12","author":"Halim-Fikri","year":"2022","journal-title":"J Pers Med"}],"container-title":["The Lancet Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352302626001973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352302626001973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:06:34Z","timestamp":1791327994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352302626001973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":147,"alternative-id":["S2352302626001973"],"URL":"https:\/\/doi.org\/10.1016\/s2352-3026(26)00197-3","relation":{},"ISSN":["2352-3026"],"issn-type":[{"value":"2352-3026","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Future-proofing thalassaemia care: harnessing scalable therapies, artificial intelligence, and global collaboration","name":"articletitle","label":"Article Title"},{"value":"The Lancet Haematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2352-3026(26)00197-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2352-3026(26)00222-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2352-3026(26)00227-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}